Shuqi Wang
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway.
Journal: Diabetology & metabolic syndrome
Published: January 29, 2025
Semaglutide attenuates lipotoxicity-induced cardiac injury by inhibiting Slc27a2 expression.
Journal: Chemico-biological interactions
Published: January 04, 2025
Inflammatory Response and Anti-Inflammatory Treatment in Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS).
Journal: Journal of inflammation research
Published: November 14, 2024
Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: September 29, 2024
Association Between Triglyceride-Glucose Index and Lung Function Parameters in the General Population Undergoing Health Examinations.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: July 19, 2024
Relationship Between the Hemoglobin, Albumin, Lymphocyte Count, Platelet Count (HALP) Score and Type 2 Diabetes Retinopathy.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 01, 2024
High Apolipoprotein B/Apolipoprotein A1 is Associated with Vitamin D Deficiency Among Type 2 Diabetes Patients.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: February 22, 2024
Epidemiological Characterisation of Chronic Diseases Among Civil Servants in Hebei Province, China: A Cross-Sectional Real-World Study of Approximately 50,000 Adults.
Journal: Risk management and healthcare policy
Published: February 08, 2024
The Relationship Between UA/HDL and Diabetic Peripheral Neuropathy: A Cross-Sectional Analysis.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 02, 2023
Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: October 22, 2023
Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 29, 2023
Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression.
Journal: Molecular and cellular biochemistry
Published: April 19, 2023
Last Updated: 09/26/2026